Data as of Jul 25
| -0.71 / -3.16%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 34.00, with a high estimate of 51.00 and a low estimate of 26.00. The median estimate represents a +56.18% increase from the last price of 21.77.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.